Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-39.85	-40.33	-87.97	-34.51	-22.81	-16.01
Depreciation & Amortization	0.38	0.37	0.37	0.2	0.18	0.18
Share-Based Compensation	6.86	6.55	8.15	7.9	3.17	1.31
Other Operating Activities	-5.73	-6.12	51.02	-2.51	4.25	0.66
Operating Cash Flow	-38.34	-39.53	-28.42	-28.91	-15.21	-13.86
Acquisitions	0	0	0	0	11.04	0
Change in Investments	-5.17	-45.29	0	0	0	0
Investing Cash Flow	-5.17	-45.29	0	0	11.04	0
Share Issuance / Repurchase	0	33.02	0	-0.45	14.36	9.68
Other Financing Activities	-	-	-	-	95.23	-
Financing Cash Flow	0	33.02	0	-0.45	109.58	9.68
Net Cash Flow	-40.83	-51.8	-28.42	-29.36	105.4	-4.18
Free Cash Flow	-38.34	-39.53	-28.42	-28.91	-15.21	-13.86
Free Cash Flow Per Share	-1.28	-1.61	-1.99	-1.95	-10.48	-21.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).